NCT00321035View on ClinicalTrials.gov

Ologen (OculusGen)-Glaucoma and Pterygium Historical Control Study in Beijing Remin Hospital

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

January 31, 2008

Conditions
GlaucomaPterygium
Interventions
DEVICE

OculusGen Biodegradable Collagen Matrix Implant

Trial Locations (1)

100044

Renmin Hospital of Beijing University, Beijing

All Listed Sponsors
lead

Pro Top & Mediking Company Limited

INDUSTRY

NCT00321035 - Ologen (OculusGen)-Glaucoma and Pterygium Historical Control Study in Beijing Remin Hospital | Biotech Hunter | Biotech Hunter